Roche seals licensing deal for antibiotic-boosting drug to battle superbugs

Reuters: Business

ZURICH (Reuters) - Roche has boosted its efforts to tackle antibiotic resistance, striking a deal worth up to $750 million with Japan's Meiji Seika Pharma and Canada's Fedora for a drug that can restore the power of antibiotics to combat infections.

view Reuters: Business